FDA Inspection
American National Red CrossFDA Inspection 1023989 - American National Red Cross - August 24, 2017
Record Details
This FDA Inspection record concerns American National Red Cross, with an inspection on August 24, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- American National Red Cross
- Inspection Date
- August 24, 2017
- Product Type
- Biologics
View Company Profile
ID · 6722a0c2-8d0b-4275-bdb1-3407cea85e9f
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1023989
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of American National Red Cross
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 13, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 14, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 20, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 19, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 17, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American National Red Cross
- FDA Inspection 1229877 - 2024-03-13
- FDA Inspection 1094437 - 2019-06-14
- FDA Inspection 919704 - 2015-03-20
- FDA Inspection 848901 - 2013-09-19
- FDA Inspection 732548 - 2011-06-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.